Up and down regulation: clinical significance of nervous system receptor-drug interactions.
D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D001569:Benzodiazepines; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology; D006801:Humans; D009420:Nervous System / Q000187:drug effects*; D010300:Parkinson Disease / Q000503:physiopathology; D011433:Propranolol / Q000494:pharmacology; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D017981:Receptors, Neurotransmitter; D001569:Benzodiazepines; D011433:Propranolol